Literature DB >> 33535825

Temporal changes in the muscle extracellular matrix due to volumetric muscle loss injury.

Daniel B Hoffman1, Christiana J Raymond-Pope1, Jacob R Sorensen1, Benjamin T Corona2, Sarah M Greising1.   

Abstract

PURPOSE/AIM: Volumetric muscle loss (VML) is a devastating orthopedic injury resulting in chronic persistent functional deficits, loss of joint range of motion, pathologic fibrotic deposition and lifelong disability. However, there is only limited mechanistic understanding of VML-induced fibrosis. Herein we examined the temporal changes in the fibrotic deposition at 3, 7, 14, 28, and 48 days post-VML injury.
MATERIALS AND METHODS: Adult male Lewis rats (n = 39) underwent a full thickness ~20% (~85 mg) VML injury to the tibialis anterior (TA) muscle unilaterally, the contralateral TA muscle served as the control group. All TA muscles were harvested for biochemical and histologic evaluation.
RESULTS: The ratio of collagen I/III was decreased at 3, 7, and 14 days post-VML, but significantly increased at 48 days. Decorin content followed an opposite trend, significantly increasing by day 3 before dropping to below control levels by 48 days. Histological evaluation of the defect area indicates a shift from loosely packed collagen at early time points post-VML, to a densely packed fibrotic scar by 48 days.
CONCLUSIONS: The shift from early wound healing efforts to a fibrotic scar with densely packed collagen within the skeletal muscle occurs around 21 days after VML injury through dogmatic synchronous reduction of collagen III and increase in collagen I. Thus, there appears to be an early window for therapeutic intervention to prevent pathologic fibrous tissue formation, potentially by targeting CCN2/CTGF or using decorin as a therapeutic.

Entities:  

Keywords:  Collagen; fibrosis; neuromusculoskeletal injury; orthopedic trauma; skeletal muscle injury

Mesh:

Substances:

Year:  2021        PMID: 33535825      PMCID: PMC8364566          DOI: 10.1080/03008207.2021.1886285

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  59 in total

Review 1.  Volumetric muscle loss.

Authors:  Brian F Grogan; Joseph R Hsu
Journal:  J Am Acad Orthop Surg       Date:  2011       Impact factor: 3.020

2.  Losartan administration reduces fibrosis but hinders functional recovery after volumetric muscle loss injury.

Authors:  Koyal Garg; Benjamin T Corona; Thomas J Walters
Journal:  J Appl Physiol (1985)       Date:  2014-09-25

3.  Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release.

Authors:  K Imai; A Hiramatsu; D Fukushima; M D Pierschbacher; Y Okada
Journal:  Biochem J       Date:  1997-03-15       Impact factor: 3.857

4.  Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation.

Authors:  Javier Barallobre-Barreiro; Shashi K Gupta; Anna Zoccarato; Rika Kitazume-Taneike; Marika Fava; Xiaoke Yin; Tessa Werner; Marc N Hirt; Anna Zampetaki; Alessandro Viviano; Mei Chong; Marshall Bern; Antonios Kourliouros; Nieves Domenech; Peter Willeit; Ajay M Shah; Marjan Jahangiri; Liliana Schaefer; Jens W Fischer; Renato V Iozzo; Rosa Viner; Thomas Thum; Joerg Heineke; Antoine Kichler; Kinya Otsu; Manuel Mayr
Journal:  Circulation       Date:  2016-08-24       Impact factor: 29.690

5.  Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis.

Authors:  Yong Li; William Foster; Bridget M Deasy; Yisheng Chan; Victor Prisk; Ying Tang; James Cummins; Johnny Huard
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

6.  Decorin and biglycan expression is differentially altered in several muscular dystrophies.

Authors:  Simona Zanotti; Tiziana Negri; Cristina Cappelletti; Pia Bernasconi; Eleonora Canioni; Claudia Di Blasi; Elena Pegoraro; Corrado Angelini; Patrizia Ciscato; Alessandro Prelle; Renato Mantegazza; Lucia Morandi; Marina Mora
Journal:  Brain       Date:  2005-09-23       Impact factor: 13.501

7.  Collagen VI regulates satellite cell self-renewal and muscle regeneration.

Authors:  Anna Urciuolo; Marco Quarta; Valeria Morbidoni; Francesca Gattazzo; Sibilla Molon; Paolo Grumati; Francesca Montemurro; Francesco Saverio Tedesco; Bert Blaauw; Giulio Cossu; Giovanni Vozzi; Thomas A Rando; Paolo Bonaldo
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

8.  Multiscale analysis of a regenerative therapy for treatment of volumetric muscle loss injury.

Authors:  Carlos A Aguilar; Sarah M Greising; Alain Watts; Stephen M Goldman; Chelsea Peragallo; Christina Zook; Jacqueline Larouche; Benjamin T Corona
Journal:  Cell Death Discov       Date:  2018-02-20

9.  Inhibition of COX1/2 alters the host response and reduces ECM scaffold mediated constructive tissue remodeling in a rodent model of skeletal muscle injury.

Authors:  Christopher L Dearth; Peter F Slivka; Scott A Stewart; Timothy J Keane; Justin K Tay; Ricardo Londono; Qingnian Goh; Francis X Pizza; Stephen F Badylak
Journal:  Acta Biomater       Date:  2015-12-02       Impact factor: 8.947

10.  Inflammatory and Physiological Consequences of Debridement of Fibrous Tissue after Volumetric Muscle Loss Injury.

Authors:  Benjamin T Corona; Jessica C Rivera; Sarah M Greising
Journal:  Clin Transl Sci       Date:  2017-11-28       Impact factor: 4.689

View more
  1 in total

1.  Secondary denervation is a chronic pathophysiologic sequela of volumetric muscle loss.

Authors:  Jacob R Sorensen; Daniel B Hoffman; Benjamin T Corona; Sarah M Greising
Journal:  J Appl Physiol (1985)       Date:  2021-04-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.